FDA Clearance Tracker · DEN170049
Innovo
Last checked: Nov 20, 2026Latest source record: Nov 6, 2018 (this decision)Source: openFDAMethods & limitations
Decided
Nov 6, 2018
De Novo granted
Time to decision
414 days
Received Sep 18, 2017. Calendar days, including time FDA spent waiting on the applicant.
Pathway
De Novo
Direct
Device class
Class II
The decision
- FDA number
- DEN170049
- Device name
- Innovo
- Applicant
- Bio-Medical Research, Ltd.
- Applicant location
- Galway, IE
- Received
- Sep 18, 2017
- Decided
- Nov 6, 2018
- Decision
- De Novo granted
- Submission type
- Direct
Device type
- Device class
- Class II
- Regulation
- 21 CFR 876.5330
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- FDA granted this as a De Novo request, which means it created a new device type. There was no existing device to compare it to.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for DEN170049
- Decision summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
Other decisions for Bio-Medical Research, Ltd.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K203513 · Decided Feb 10, 2021 · 72 days after receipt
Device type: Stimulator, Muscle, Powered, For Muscle Conditioning (NGX) · Physical Medicine & Rehabilitation
K180688 · Decided Oct 25, 2018 · 224 days after receipt
Device type: Stimulator, Muscle, Powered, For Muscle Conditioning (NGX) · Physical Medicine & Rehabilitation
K161974 · Decided Nov 1, 2016 · 106 days after receipt
Device type: Stimulator, Muscle, Powered, For Muscle Conditioning (NGX) · Physical Medicine & Rehabilitation
1 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.